New Benchmarks Set to Revolutionize Financial Analysis in Drug Discovery Sector
Financial ratio analysis is used to compare the financial health of companies in the Drug Discovery Services sector. By looking at indicators like balance sheets and profit statements, benchmarks were created for key financial ratios of 10 publicly listed companies. This helps stakeholders understand how these companies are performing financially over the last 5 years. The goal was to provide a way to compare the financial ratios of these companies and assess their performance in the market.